| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Yong-Ku Kim | |
| Eunsoo Won | |||
| P2860 | cites work | Neuroinflammation and psychiatric illness | Q21245244 |
| Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseases | Q21285076 | ||
| Glia in the cytokine-mediated onset of depression: fine tuning the immune response | Q26798929 | ||
| Clinical and biochemical manifestations of depression: relation to the neurobiology of stress | Q26824899 | ||
| The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system | Q28140631 | ||
| Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS | Q28264128 | ||
| Human microglia convert l-tryptophan into the neurotoxin quinolinic acid | Q28379366 | ||
| Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior | Q28508390 | ||
| Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway | Q28574225 | ||
| Cholecystokinin receptors | Q28608935 | ||
| Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin | Q29615449 | ||
| Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis | Q30687949 | ||
| Stress, depression and immunity: the role of defense and coping styles | Q33589426 | ||
| Mood and cognitive disorders in cancer patients receiving cytokine therapy | Q33708121 | ||
| Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress | Q33708133 | ||
| Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? | Q33740214 | ||
| CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression | Q33751166 | ||
| Clinical and physiological consequences of rapid tryptophan depletion | Q34076826 | ||
| Inflammation-associated depression: from serotonin to kynurenine | Q34147377 | ||
| The effects of tryptophan depletion on mood and psychiatric symptoms | Q34225636 | ||
| Expression of the kynurenine pathway enzymes in human microglia and macrophages | Q34327818 | ||
| The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis | Q34350872 | ||
| Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons | Q34351574 | ||
| Neopterin production, tryptophan degradation, and mental depression--what is the link? | Q34528385 | ||
| The macrophage theory of depression | Q34607619 | ||
| Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. | Q34655648 | ||
| Characteristics of interferon induced tryptophan metabolism in human cells in vitro | Q61906378 | ||
| Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice | Q72227813 | ||
| Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro | Q72332708 | ||
| Heterogeneity in neuroendocrine and immune responses to brief psychological stressors as a function of autonomic cardiac activation | Q72338129 | ||
| Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions | Q73333458 | ||
| Differential effects of kynurenine and tryptophan treatment on quinolinate immunoreactivity in rat lymphoid and non-lymphoid organs | Q77146447 | ||
| Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system | Q77512461 | ||
| The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder | Q79747553 | ||
| Cytokine imbalance in the pathophysiology of major depressive disorder | Q80156883 | ||
| Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect | Q34661622 | ||
| l-Kynurenine Its synthesis and possible regulatory function in brain | Q34661906 | ||
| IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation | Q34674495 | ||
| Physiology of the autonomic nervous system | Q34677159 | ||
| The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase | Q34715866 | ||
| Psychoneuroimmunology: interactions between the nervous system and the immune system | Q34722770 | ||
| The increasing burden of depression | Q35090232 | ||
| Tryptophan and the immune response | Q35171881 | ||
| Tryptophan as a link between psychopathology and somatic states | Q35185860 | ||
| Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? | Q35225947 | ||
| Sickness behavior as a new target for drug development | Q35899947 | ||
| Stress, depression, the immune system, and cancer | Q35909595 | ||
| Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway | Q35944934 | ||
| The cholinergic anti-inflammatory pathway | Q36142829 | ||
| Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity | Q36821053 | ||
| Cholinergic modulation of inflammation. | Q36992793 | ||
| The possible role of the kynurenine pathway in adolescent depression with melancholic features | Q37012125 | ||
| The involvement of astrocytes and kynurenine pathway in Alzheimer's disease. | Q37059457 | ||
| Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder | Q37348823 | ||
| Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? | Q37492248 | ||
| Quinolinic Acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms | Q37992617 | ||
| Integrative physiology of depression and antidepressant drug action: implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depression | Q38047161 | ||
| Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants | Q38159858 | ||
| Immunology of major depression | Q38189994 | ||
| Lost among the trees? The autonomic nervous system and paediatrics | Q38191480 | ||
| Inflammation as the cause of the metabolic syndrome in depression | Q38249986 | ||
| The kynurenine pathway and neurodegenerative disease. | Q38378952 | ||
| Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. | Q38410039 | ||
| The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies | Q38538956 | ||
| Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis | Q39445647 | ||
| Experimental induction and termination of acute psychological stress in human volunteers: effects on immunological, neuroendocrine, cardiovascular, and psychological parameters | Q39448732 | ||
| Acute stress induces proinflammatory signaling at chronic inflammation sites | Q40045939 | ||
| Characterization of the kynurenine pathway in human neurons | Q40046237 | ||
| Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents | Q40141603 | ||
| Mild acute inflammatory stimulation induces transient negative mood | Q40524480 | ||
| Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages. | Q41555828 | ||
| Exocytosis in chromaffin cells of the adrenal medulla | Q41729422 | ||
| Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment | Q41734310 | ||
| Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones | Q41967745 | ||
| The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. | Q42486512 | ||
| Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes | Q42518846 | ||
| Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease. | Q42948425 | ||
| Cytokine-associated emotional and cognitive disturbances in humans | Q43601371 | ||
| Heart rate, neuroendocrine, and immunological reactivity in response to an acute laboratory stressor | Q43623737 | ||
| Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection | Q43718624 | ||
| Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system | Q43859445 | ||
| Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. | Q44040242 | ||
| Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation | Q44100268 | ||
| Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression | Q44638979 | ||
| On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress. | Q45925096 | ||
| Socioeconomic status and stress-induced increases in interleukin-6. | Q47861387 | ||
| Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy | Q47861479 | ||
| The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. | Q48002329 | ||
| Kynurenine pathway (KP) inhibitors: Novel agents for the management of depression | Q48076319 | ||
| Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression | Q48208784 | ||
| Role of cytokines in atypical depression | Q48282089 | ||
| 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity | Q48568701 | ||
| The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture | Q48577725 | ||
| Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism | Q48715601 | ||
| Cingulate function in depression: a potential predictor of treatment response | Q48768060 | ||
| Acute inflammation and negative mood: mediation by cytokine activation | Q48863588 | ||
| Excitation and inhibition of rat sympathetic preganglionic neurones by catecholamines | Q48877481 | ||
| An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid | Q48898368 | ||
| Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. | Q51080831 | ||
| 3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Generate Hydrogen Peroxide and Promote α-Crystallin Cross-Linking by Metal Ion Reduction† | Q57080763 | ||
| Kynurenine pathway in major depression: Evidence of impaired neuroprotection | Q58835693 | ||
| The plasma levels of interleukin-12 in schizophrenia, major depression and bipolar mania: effects of psychotropic drugs | Q59672858 | ||
| Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression | Q60414725 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nervous system | Q9404 |
| amino acid | Q8066 | ||
| psychological stress | Q3500368 | ||
| major depressive disorder | Q42844 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 665-673 | |
| P577 | publication date | 2015-12-07 | |
| 2016-01-01 | |||
| P1433 | published in | Current Neuropharmacology | Q20181354 |
| P1476 | title | Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression | |
| Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression | |||
| P478 | volume | 14 |
| Q37726720 | Association between depressive disorders and risk of breast cancer recurrence after curative surgery |
| Q89957376 | Association between depressive symptoms and arterial stiffness: a cross-sectional study in the general Chinese population |
| Q90723386 | Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk |
| Q52543725 | Concussion and the autonomic nervous system: An introduction to the field and the results of a systematic review. |
| Q37650028 | Depressive disorder and gastrointestinal dysfunction after myocardial infarct are associated with abnormal tryptophan-5-hydroxytryptamine metabolism in rats |
| Q64976718 | Determination of Optimal Heart Rate Variability Features Based on SVM-Recursive Feature Elimination for Cumulative Stress Monitoring Using ECG Sensor. |
| Q90479259 | Dietary intake of tryptophan tied emotion-related impulsivity in humans |
| Q64900484 | Exposure to Workplace Bullying, Distress, and Insomnia: The Moderating Role of the miR-146a Genotype. |
| Q53438486 | Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice. |
| Q38787388 | Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies |
| Q91951348 | Good, better, best: clinical scenarios for the use of L-methylfolate in patients with MDD |
| Q91925610 | Inflammation in cancer and depression: a starring role for the kynurenine pathway |
| Q56916789 | Long-term relief from tension-type headache and major depression following chiropractic treatment |
| Q91790981 | Mechanisms supporting potential use of bone marrow-derived mesenchymal stem cells in psychocardiology |
| Q41718646 | Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study. |
| Q90092593 | Negative life events and major depressive disorder among HIV-positive individuals in Guangdong, China: A cross-sectional study |
| Q64969956 | Neuronal nitric oxide synthase and affective disorders. |
| Q90665100 | Regulatory mechanisms of major depressive disorder risk variants |
| Q64948002 | The Neuroscience of Nonpharmacological Traditional Chinese Therapy (NTCT) for Major Depressive Disorder: A Systematic Review and Meta-Analysis. |
Search more.